Litcius/Paper detail

The Differential Risk of Mortality Among Users of Overactive Bladder Anticholinergic Medications and β3 Agonists

Blayne Welk

2022European Urology Focus13 citationsDOI

Topics & Concepts

AnticholinergicOveractive bladderOxybutyninMedicineAnticholinergic agentsTolterodineAgonistInternal medicineUrologyIntensive care medicineAlternative medicineReceptorPathologyUrinary Bladder and Prostate ResearchPelvic floor disorders treatmentsUrinary Tract Infections Management
The Differential Risk of Mortality Among Users of Overactive Bladder Anticholinergic Medications and β3 Agonists | Litcius